VHIBF
OTCM
Market cap269mUSD
Nov 20, Last price
4.20USD
1D
-5.66%
1Q
-27.59%
IPO
76.47%
Name
Vitalhub Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Vitalhub Corp., through its subsidiaries, provides innovative technological solutions to health and human service providers internationally, specifically catering to markets in Canada, the United States, the United Kingdom, Australia, and Western Asia. The company's diverse array of offerings comprises electronic healthcare records, case management systems, care coordination platforms, tools for optimizing patient flow and operational insights, and various mobile applications. Incorporated in 2010, Vitalhub is headquartered in Toronto, Canada.
Key people
Non-Executive Chairman of the Board · since 2023
Daniel Matlow
President, Chief Executive Officer, Director · since 2016
Brian Goffenberg
Chief Financial Officer, Executive Vice President · since 2020
Mike Sanders
Chief Executive Officer, VitalHub UK · since 2023
Patrick Mazza
Chief Operating Officer · since 2024
Vijit Coomara
Executive Vice President - Product Development · since 2017
Robert Lazar
Executive Vice President - Professional Services and Customer Care · since 2017
Niels Tofting
Executive Vice President, Managing Director of North American Operations · since 2024
Lisa Riley
Deputy Chief Executive Officer, Vice President - Strategy and Sales · since 2023
Independent Director · since 2016
Stephen Garrington
Independent Director · since 2016
Independent Director · since 2021
Independent Director · since 2016
Headquarters & legal address
1001-480 University Avenue
Toronto, ON M5G 1V2
CA
Toronto, ON M5G 1V2
CA
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||